UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Influence of Acute and Chronic Mineralocorticoid Excess on Endothelial Function in Healthy Men

Hypertension (Dallas, Tex. 1979), 2007-07, Vol.50 (1), p.82-88

2007

Volltextzugriff (PDF)

Functional and Biochemical Analysis of Angiotensin II-Forming Pathways in the Human Heart

Circulation research, 1997-02, Vol.80 (2), p.219-227

1997

Volltextzugriff (PDF)

Prolonged Oxygen Uptake Kinetics During Low-Intensity Exercise Are Related to Poor Prognosis in Patients With Mild-to-Moderate Congestive Heart Failure

Chest, 2003-08, Vol.124 (2), p.580-586

2003

Volltextzugriff (PDF)

Drug-eluting or bare-metal stents for large coronary vessel stenting? The BASKET-PROVE (PROspective Validation Examination) trial: Study protocol and design

The American heart journal, 2008-04, Vol.155 (4), p.609-614

2008

Volltextzugriff (PDF)

Combining low-intensity and maximal exercise test results improves prognostic prediction in chronic heart failure

Journal of the American College of Cardiology, 2003-07, Vol.42 (1), p.116-122

2003

Volltextzugriff (PDF)

Effects of percutaneous coronary interventions in silent ischemia after myocardial infarction: the SWISSI II randomized controlled trial

JAMA : the journal of the American Medical Association, 2007-05, Vol.297 (18), p.1985

2007

Volltextzugriff (PDF)

Endothelial function and dysfunction. Part II: Association with cardiovascular risk factors and diseases. A statement by the Working Group on Endothelins and Endothelial Factors of the European Society of Hypertension

Journal of hypertension, 2005-02, Vol.23 (2), p.233-246

2005

Volltextzugriff (PDF)

Noninvasive Assessment of Cardiac Pumping Capacity During Exercise Predicts Prognosis in Patients with Congestive Heart Failure

Chest, 2002-10, Vol.122 (4), p.1333-1339

2002

Volltextzugriff (PDF)

The therapeutic potential of endothelin receptor antagonists in cardiovascular disease

Current hypertension reports, 2001-08, Vol.3 (4), p.322-330

2001

Volltextzugriff (PDF)

Noninvasive Evaluation of Pulmonary Capillary Wedge Pressure by BP Response to the Valsalva Maneuver

Chest, 2002-07, Vol.122 (1), p.140-145

2002

Volltextzugriff (PDF)

Up-Regulation of Endothelin-B Receptors in Atherosclerotic Human Coronary Arteries

Journal of cardiovascular pharmacology, 1996-01, Vol.27 (1), p.147-153

1996

Volltextzugriff (PDF)

Clinical effects of endothelin receptor antagonism with bosentan in patients with severe chronic heart failure: results of a pilot study

Journal of cardiac failure, 2005-02, Vol.11 (1), p.12-20

2005

Volltextzugriff (PDF)

Cardiac allograft rejection late after transplantation is a risk factor for graft coronary artery disease

Transplantation, 1998-02, Vol.65 (4), p.538-543

1998

Volltextzugriff (PDF)

Systemic endothelial dysfunction in adults with cyanotic congenital heart disease

Circulation (New York, N.Y.), 2005-08, Vol.112 (8), p.1106-1112

2005

Volltextzugriff (PDF)

Acute and short-term effects of the nonpeptide endothelin-1 receptor antagonist bosentan in humans

Cardiovascular drugs and therapy, 1997, Vol.10 (6), p.717-725

1997

Volltextzugriff (PDF)

Tezosentan (an intravenous endothelin receptor A/B antagonist) reduces peripheral resistance and increases cardiac power therefore preventing a steep decrease in blood pressure in patients with congestive heart failure

European journal of heart failure, 2001-08, Vol.3 (4), p.457-461

2001

Volltextzugriff (PDF)

Why and how do elderly patients with heart failure die? Insights from the TIME-CHF study

European journal of heart failure, 2012-11, Vol.14 (11), p.1218-1229

2012

Volltextzugriff (PDF)

Is Blood Pressure Response to the Valsalva Maneuver Related to Neurohormones, Exercise Capacity, and Clinical Findings in Heart Failure?

Chest, 1999-10, Vol.116 (4), p.861-867

1999

Volltextzugriff (PDF)

B-type natriuretic peptide in patients with sepsis and preserved left ventricular ejection fraction

European journal of heart failure, 2005-12, Vol.7 (7), p.1164-1167

2005

Volltextzugriff (PDF)

Rationale and Perspective of Endothelin-1 Antagonism in Acute Heart Failure

Journal of cardiovascular pharmacology, 2001-11, Vol.38 Suppl 2, p.S53-S57

2001

Volltextzugriff (PDF)

Short-term oral endothelin-receptor antagonist therapy in conventionally treated patients with symptomatic severe chronic heart failure

Circulation (New York, N.Y.), 1998-11, Vol.98 (21), p.2262-2268

1998

Volltextzugriff (PDF)

Plasma levels of enalaprilat in chronic therapy of heart failure: relationship to adverse events

The Journal of pharmacology and experimental therapeutics, 1999-04, Vol.289 (1), p.565

1999

Volltextzugriff (PDF)

Stereoselective Vascular Effects of the (R)- and (S)-Enantiomers of Propranolol and Atenolol

Journal of cardiovascular pharmacology, 1995-02, Vol.25 (2), p.268-272

1995

Volltextzugriff (PDF)

1 – 25 von 156

Suche als RSS-Feed

Aktive Filter

KollektionOxford Journals 2020 Medicine

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(149)
Mit Volltextzugriff
(135)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Influence of Acute and Chronic Mineralocorticoid Excess on Endothelial Function in Healthy Men

Functional and Biochemical Analysis of Angiotensin II-Forming Pathways in the Human Heart

Prolonged Oxygen Uptake Kinetics During Low-Intensity Exercise Are Related to Poor Prognosis in Patients With Mild-to-Moderate Congestive Heart Failure

Drug-eluting or bare-metal stents for large coronary vessel stenting? The BASKET-PROVE (PROspective Validation Examination) trial: Study protocol and design

Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document

Combining low-intensity and maximal exercise test results improves prognostic prediction in chronic heart failure

Effects of percutaneous coronary interventions in silent ischemia after myocardial infarction: the SWISSI II randomized controlled trial

Endothelial function and dysfunction. Part II: Association with cardiovascular risk factors and diseases. A statement by the Working Group on Endothelins and Endothelial Factors of the European Society of Hypertension

Noninvasive Assessment of Cardiac Pumping Capacity During Exercise Predicts Prognosis in Patients with Congestive Heart Failure

The therapeutic potential of endothelin receptor antagonists in cardiovascular disease

Noninvasive Evaluation of Pulmonary Capillary Wedge Pressure by BP Response to the Valsalva Maneuver

Up-Regulation of Endothelin-B Receptors in Atherosclerotic Human Coronary Arteries

Clinical effects of endothelin receptor antagonism with bosentan in patients with severe chronic heart failure: results of a pilot study

Cardiac allograft rejection late after transplantation is a risk factor for graft coronary artery disease

Systemic endothelial dysfunction in adults with cyanotic congenital heart disease

Acute and short-term effects of the nonpeptide endothelin-1 receptor antagonist bosentan in humans

Tezosentan (an intravenous endothelin receptor A/B antagonist) reduces peripheral resistance and increases cardiac power therefore preventing a steep decrease in blood pressure in patients with congestive heart failure

Why and how do elderly patients with heart failure die? Insights from the TIME-CHF study

2007 ESH-ESC Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)

Is Blood Pressure Response to the Valsalva Maneuver Related to Neurohormones, Exercise Capacity, and Clinical Findings in Heart Failure?

B-type natriuretic peptide in patients with sepsis and preserved left ventricular ejection fraction

Rationale and Perspective of Endothelin-1 Antagonism in Acute Heart Failure

Short-term oral endothelin-receptor antagonist therapy in conventionally treated patients with symptomatic severe chronic heart failure

Plasma levels of enalaprilat in chronic therapy of heart failure: relationship to adverse events

Stereoselective Vascular Effects of the (R)- and (S)-Enantiomers of Propranolol and Atenolol

Aktive Filter

Suchergebnisse filtern